Cigarette smoking and glutathione S-transferase M1 polymorphism associated with risk for uterine cervical cancer

Journal of Obstetrics and Gynaecology Research

Volumn 34, Issue 6, 2008, Pages 994-1001

  Nishino, Koji ^a   Sekine, Masayuki ^a   Kodama, Shoji ^b   Sudo, Norihito ^c   Aoki, Yoichi ^d   Seki, Nao ^e   Tanaka, Kenichi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA CANCER CENTER HOSPITAL   (Japan)

^c NAGAOKA RED CROSS HOSPITAL   (Japan)

^d UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^e NIIGATA UNIVERSITY   (Japan)

Author keywords

Glutathione S transferase M1; Human papilloma virus; Polymorphism; Smoking; Uterine cervical cancer

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; COCARCINOGENESIS; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; SMOKING; UTERINE CERVICAL NEOPLASMS;

EID: 55649102718     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.00798.x     Document Type: Article

References (38)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005 55 : 74 108.
2. Ioka A, Tsukuma H, Ajiki W, Oshima A. Trends in uterine cancer incidence in Japan 1975-1998. Jpn J Clin Oncol 2003 33 : 645 646.
3. zur Hausen H. Papillomaviruses in human cancers. Mol Carcinog 1998 1 : 147 150.
4. Castellsague X, Boscho FX, Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Res 2002 89 : 191 199.
5. Winkelstein W Jr. Smoking and cancer of the uterine cervix: Hypothesis. Am J Epidemiol 1977 106 : 257 259.
6. Plummer M, Herrero R, Franceschi S et al. IARC Multi-centre Cervical Cancer Study Group. Smoking and cervical cancer: Pooled analysis of the IARC multi-centric case-control study. Cancer Causes Contorl 2003 9 : 805 814.
7. Melikian AA, Sun P, Prokopczyk B et al. Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. Cancer Lett 1999 146 : 127 134.
8. Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 1997 89 : 868 873.
9. The 1998 Fiscal Year Survey about Smoking and a Healthy Problem. Tokyo : Ministry of Health, Labour and Welfare, 1998.
10. Wu X, Zhao H, Suk R, Christiani DC. Genetic susceptibility to tobacco-related cancer. Oncogene 2004 23 : 6500 6523.
11. Le Marchand L, Sivaraman L, Pierce L et al. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 1998 58 : 4858 4863.
12. Kato S, Shields PG, Caporaso NE et al. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res 1992 52 : 6712 6715.
13. Kim RB, O'Shea D, Wilkinson GR. Relationship in healthy subjects between CYP2E1 genetic polymorphisms and the 6-hydroxylation of chlorzoxazone: A putative measure of CYP2E1 activity. Pharmacogenetics 1994 4 : 162 165.
14. Ariyoshi N, Takahashi Y, Miyamoto M et al. Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C. Pharmacogenetics 2000 10 : 687 693.
15. Chen H, Lum A, Seifried A, Willens LR, Le Marchand L. Association of the NAD(P)H: Quinone oxidoreductase 609 C→T polymorphism with a decreased lung cancer risk. Cancer Res 1999 59 : 3045 3048.
16. Park SJ, Zhao H, Spitz MR, Grossman HB, Wu X. An association between NQO1 genetic polymorphism and risk of bladder cancer. Mutat Res 2003 536 : 131 137.
17. Niwa Y, Hirose K, Nakanishi T et al. Association of the NAD(P)H: Quinone oxidoreductase C609T polymorphism and the risk of cervical cancer in Japanese subjects. Gynecol Oncol 2005 96 : 423 429.
18. Nyberg F, Hou SM, Hemminki K, Lambert B, Pershagen G. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Cancer Epidemiol Biomarkers Prev 1998 7 : 875 883.
19. Costa S, Medeiros R, Vasconcelos A, Pinto D, Lopes C. A slow acetylator genotype associated with an increased risk of advanced cervical cancer. J Cancer Res Clin Oncol 2002 128 : 678 682.
20. Garcia-Closas M, Malats N, Silverman D et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analysis. Lancet 2005 366 : 649 659.
21. Hassett C, Aicher L, Sidus JS, Omiecinski C. Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 1994 3 : 421 428.
22. Wu X, Gwyn K, Amos CI, Makan N, Hong WK, Spitz MR. The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans. Carcinogenesis 2001 22 : 923 928.
23. Lin YC, Wu DC, Lee JM et al. The association between microsomal epoxide hydrolase genotypes and esophageal squamous-cell-carcinoma in Taiwan: Interaction between areca chewing and smoking. Cancer Lett 2006 237 : 281 288.
24. LeMarchand L, Seifried A, Lum A, Wilkens LR. Association of the Myeloperoxidase 463 G→A Polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000 9 : 181 184.
25. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H, Iwamoto A. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 1991 82 : 524 531.
26. Spurdle AB, Webb PM, Purdie DM, Chen X, Green A, Chenevix-Trench G. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci: Risk of ovarian cancer by histological subtype. Carcinogenesis 2001 22 : 67 72.
27. Masumoto N, Fujii T, Ishikawa M et al. Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women. Br J Cancer 2003 88 : 1883 1888.
28. Cancer Incidence in Five Continents CANCER Mondial. Lyon: International Agency for Research on Cancer, World Health Organization, 2005. Available from URL: http://www-dep.iarc.fr
29. Marugame T, Hamashima C. Mortality trend of uterine cancer in Japan: 1960-2000. Jpn J Clin Oncol 2004 34 : 55 56.
30. Goodman MT, McDuffie K, Hernandez B et al. CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol Oncol 2001 81 : 263 269.
31. Kim JW, Lee CG, Park YG et al. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: Relation to the incidence rate of cervical carcinoma. Cancer 2000 88 : 2082 2091.
32. Sierra-Torres CH, Au WW, Arrastia CD et al. Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia. Environ Mol Mutagen 2003 41 : 69 76.
33. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: Examination of the evidence. J Natl Cancer Inst 1996 88 : 183 192.
34. Kuper H, Boffetta P, Adami HO. Tobacco use and cancer causation: Association by tomour type. J Intern Med 2002 252 : 206 224.
35. Hsu JL, Glaser SL. Epstein-Barr virus-associated malignancies: Epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol 2000 34 : 27 53.
36. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res 2004 10 : 803 821.
37. Trimble CL, Genkinger JM, Burke AE et al. Active and passive cigarette smoking and the risk of cervical neoplasia. Obstet Gynecol 2005 105 : 174 181.
38. Tay SK, Tay KJ. Passive smoking is a risk factor in cervical neoplasia. Gynecol Oncol 2004 93 : 116 120.